title: [German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures].
authors.affiliation: Deutsche Gesellschaft für Rheumatologie (DGRh), Berlin, Deutschland, Uta.Kiltz@elisabethgruppe.de.
authors.forename: U
authors.initials: U
authors.lastname: Kiltz
authors.forename: J
authors.initials: J
authors.lastname: Sieper
authors.forename: H
authors.initials: H
authors.lastname: Kellner
authors.forename: D
authors.initials: D
authors.lastname: Krause
authors.forename: M
authors.initials: M
authors.lastname: Rudwaleit
authors.forename: J-F
authors.initials: JF
authors.lastname: Chenot
authors.forename: A
authors.initials: A
authors.lastname: Stallmach
authors.forename: S
authors.initials: S
authors.lastname: Jaresch
authors.forename: J
authors.initials: J
authors.lastname: Braun
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005858:Germany; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000592:standards*; D012219:Rheumatology / Q000592:standards*; D012955:Societies, Medical / Q000592:standards; D025241:Spondylarthritis / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents